#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study of Dostarlimab for Patients with Advanced or Metastatic Non-Colorectal/Non-Endometrial Cancer with dMMR/MSI, Compared to Standard Drug Combination

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion

    Recruiting

    2 1 1
    Investigated drugs:
    Austria Belgium Denmark France Germany Italy +4

  • Study on the Safety and Tolerability of D3S-001 Alone or with Drug Combination in Adults with Advanced Solid Tumors with KRAS p.G12C Mutation

    Recruiting

    2 1 1 1
    Investigated drugs:
    France Germany Italy Spain

  • Study of Tulmimetostat (CPI-0209) for Patients with Advanced Solid Tumors and Lymphomas

    Recruiting

    2 1 1 1
    Investigated drugs:
    France Italy Poland Spain

  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium Czechia Denmark France Germany Greece +6

  • Study of AZD3470 alone and in combination with other cancer drugs for patients with advanced solid tumors that are MTAP deficient

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France The Netherlands Spain

  • Study of PC14586 for Patients with Advanced Solid Tumors with a Specific TP53 Mutation

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Spain

  • Study of INBRX-109 with Irinotecan Hydrochloride Trihydrate and Temozolomide for Patients with Advanced Solid Tumors, Including Sarcomas

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy The Netherlands Spain

  • Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium France Germany Hungary Italy The Netherlands +2

  • Safety Monitoring of Crizotinib for Patients Continuing from Previous Studies

    Recruiting

    3 1 1 1
    Investigated drugs:
    Italy